Midgard Science

TRiCBIO

Nanjing, China tricbio.com From their website, Nov 2026

Work here? Claim this listing

About

TRiCBIO provides human organoid-based research services for drug discovery, efficacy, safety, mechanism, immune-context, and custom model development. It works with biopharma, CRO, and research collaboration projects, with studies run from Nanjing and project support from Shanghai and Philadelphia.

Services

  • Organoid target discovery & functional genomics

    Discover genetic dependencies through organoid library screening and validate targets with tumor, microenvironment, and treatment-response readouts.

  • Target validation & mechanism studies

    Test candidate targets in human organoids through disease phenotypes, molecular changes, and treatment response.

  • Mechanism & biomarker studies

    Link tissue, functional, and molecular results to treatment response and prioritize biomarker candidates for validation.

  • Custom model development

    Develop model and assay plans for specialized tissues, rare diseases, or complex co-cultures based on available samples and endpoints.

  • Organoid efficacy screening

    Compare single agents and combinations in tumor PDOs and selected human organoid models to identify dose responses and differences across models.

  • Immuno-oncology

    Evaluate immune activation and tumor-cell killing in PDO 2.0 / ALI models or immune co-cultures with tissue imaging and functional assays.

  • Antibody, multispecific & T-cell engager (TCE) studies

    Compare tumor-cell killing, immune activation, and cytokine changes for antibody, multispecific, and TCE candidates in human tumor organoids and immune co-cultures.

  • ADC research

    Combine target expression, spatial distribution, cytotoxicity, and bystander-effect readouts in organoid studies matched to ADC candidates.

7 more services
  • Safety & toxicology
  • Multi-organ safety in human organoids
  • Drug delivery & barrier permeability
  • Mechanism & biomarkers
  • Human intestinal organoid IBD-like inflammation model
  • Tailored ADPKD organoid cyst-phenotype studies
  • BBB co-culture & permeability methods

Capabilities

Assays and studies
  • Antibodies
  • ADCs
  • Flow cytometry
  • Toxicology
  • Small molecules
  • Library screening
18 more
  • Functional genomics
  • Target validation
  • Mechanism studies
  • Morphology
  • Histology
  • Immunofluorescence
  • Cytokine assays
  • Viability
  • Apoptosis
  • Gene expression/qPCR
  • Barrier permeability
  • Transport assays
  • Injury marker analysis
  • Genetic-library screening
  • Treatment-response studies
  • Functional assays
  • H&E
  • IHC
Scale and capacity
  • ALI · 96-well adaptable
  • 24-well · 96-well adaptable
Therapeutic areas
  • Oncology
  • Immuno-oncology
  • Kidney injury
  • Gastrointestinal disease
  • Inflammatory bowel disease
  • ADPKD
9 more
  • Blood-brain barrier
  • Head and neck cancer
  • Mesenchymal tumors
  • Drug discovery
  • Drug development
  • Safety
  • Inflammation
  • Inherited kidney disease
  • Neurovascular-barrier research

Instruments and platforms

  • Flow cytometry
  • H&E
  • IHC
  • IF
  • Microscopy equipment

Modalities and species

Modalities
  • Small molecule
  • Antibody
  • Bispecific
  • ADC
Species and models
  • Human tumor organoids
  • Human kidney organoids
  • Normal lung organoids
  • Human intestinal organoids
  • Adjacent non-tumor liver organoids
  • H9 human embryonic stem cell (hESC)-derived kidney organoids
11 more
  • HUVEC–astrocyte co-culture
  • Patient-derived tumor organoids (PDO 1.0, PDO 2.0 / ALI)
  • IBD-like intestinal organoid model
  • ADPKD hPSC-derived kidney organoids
  • Human organoids
  • PDO 1.0
  • PDO 2.0
  • ALI tumor-immune organoids
  • Tumor PDOs
  • Normal-tissue organoids
  • hPSC-derived kidney organoids

Industries served

  • Biopharma
  • CRO
  • Biotech
  • Academic research

Company

Type
CRDMO
Quality
Model QC (morphology, markers and functional readouts) · batch QC (model and assay summary, model/batch QC, original images or data, and study report) · model quality assessed through morpholog · methods, results and data sources docume

Locations

Based in
Nanjing, China
Sites
  • Shanghai, China
  • Philadelphia, US
Serves
China, global, global clients

Contacts

Similar labs